NIH/National Institute of Allergy and Infectious Diseases

HIV & AIDS

Scientists boost potential of passive immunization against HIV

Scientists are pursuing injections or intravenous infusions of broadly neutralizing HIV antibodies (bNAbs) as a strategy for preventing HIV infection. This technique, called passive immunization, has been shown to protect ...

Diseases, Conditions, Syndromes

Monoclonal antibody prevents malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found. The antibody ...

Medications

Baricitinib plus remdesivir shows promise for treating COVID-19

The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal ...

Diseases, Conditions, Syndromes

Scientists develop new mouse model to study Salmonella meningitis

National Institutes of Health (NIH) scientists have established in mice a way to study potentially life-threatening meningitis caused by Salmonella. Bacterial meningitis happens when bacteria infect the central nervous system ...

page 8 from 40